Invivo Partners promoted by Albert Ferrer and Luis Pareras, is a management company investing in early stages companies in the healthcare sector. Invivo Partners has a team of highly qualified professionals, with the scientific, technical and financial know-how required to analyse and make investments to provide value to the invested company. It also has a network of contacts and key strategic relationships in the health ecosystem.
At JORI&, we support companies, startups, and organizations in the healthcare sector in managing their risks—so they can grow with confidence.
In an ecosystem where innovation, investment, and collaboration are key, we bring a strategic view of risk as a driver of progress: from protecting R&D initiatives to managing emerging risks such as cyber, liability, and international expansion.
With more than 130 years of experience, we work alongside those transforming healthcare, helping turn opportunities into solid, sustainable projects.
Because innovation means moving forward. And moving forward also means being protected.
Kistler Group es un proveedor líder mundial de soluciones de medición dinámica de alta precisión orientadas a garantizar la calidad y la fiabilidad en procesos críticos.
En los sectores farmacétuicos, medicina y salud, Kistler ofrece tecnologías avanzadas para el control y la monitorización de procesos clave como la fabricación de medicamentos, el envasado farmacéutico, la producción de dispositivos médicos y los ensayos de laboratorio.
Nuestras soluciones permiten asegurar la trazabilidad, el cumplimiento normativo (GMP/FDA) y la consistencia del producto, reduciendo riesgos y optimizando la eficiencia operativa.
Gracias a su capacidad para capturar y evaluar datos en tiempo real con máxima precisión, Kistler ayuda a las organizaciones a mejorar la calidad del producto final, garantizar la seguridad del paciente y acelerar la validación de procesos en entornos altamente regulados.
Klinea is a process engineering company specialized in the pharmaceutical and biotechnology sectors, with deep expertise in the design of GMP-compliant facilities and highly regulated environments. We support projects across their full lifecycle—from feasibility and conceptual studies to construction management—always starting from a thorough understanding of the manufacturing process.
We are vendor-agnostic by design, which allows us to select the most suitable technologies for each client based solely on technical excellence and strategic fit. Digitalisation and sustainability are embedded from the earliest design stages, enabling us to deliver facilities that are efficient, scalable, and future-ready.
Operating across Spain and Europe, Klinea is backed by a highly specialized, multidisciplinary team with strong experience in complex, high-demand regulatory projects.
Our objective is to establish direct contact with potential customers, generate new business opportunities, and position Klinea as a strategic engineering partner for advanced pharmaceutical and biotechnology projects in the Catalonia health ecosystem.
Javier Seoane
Business Development Specialist
Partnership Goal
The aim for this event is to strengthen the sector by fostering meaningful connections, engaging with new stakeholders, and identifying opportunities for collaboration that can generate long‑term value for all participants.
Kymos Group, con 4 laboratorios en España, Italia, Alemania y Dinamarca, se dedica a proporcionar cualquier solución de bioanálisis o ensayos CMC que pueda necesitar durante todo el ciclo de vida de su producto, desde la investigación y el desarrollo tempranos hasta la fabricación y la comercialización.
Lonza is one of the world’s largest healthcare manufacturing organizations. Working across five continents, our global community of approximately 18,500 colleagues helps pharmaceutical, biotech and nutrition companies to bring their treatments to market. We support our customers with a combination of technological insight, world-class manufacturing, scientific expertise, process excellence and innovation.
Our work enables our customers to develop and commercialize their therapeutic discoveries, allowing their patients to benefit from lifesaving and life-enhancing treatments. In Advanced Synthesis, we apply more than 125 years’ expertise in classic and complex chemistry to the manufacturing of small molecules, highly potent APIs, antibody-drug conjugates and bioconjugates.
From the Innovation and Entrepreneurship Area of the Barcelona Medical Association (CoMB), we promote the CoMB MedAngels Network: a network that supports investment in healthcare startups, composed primarily of medical doctors with an interest in early stage investment.
We are a vertically integrated pharmaceutical company. We specialize in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs). Our portfolio includes approximately 45 APIs and 20 FDFs, we offer contract development and manufacturing (CDMO) and we are global leaders in chlorhexidine products.
With over half a century of industry experience, and as a recently certified B Corp, we guarantee the highest standards of quality, operational excellence, and respect for the environment.
Our team is looking forward to connecting with partners, exploring new opportunities, and strengthening collaborations across the global pharma community.
So, if you're looking for:
🔵 Securing a reliable and regulatory-compliant API supply 🟣 Portfolio expansion through in-licensing of oral solid dosage forms and sterile injectables 🟢 Leveraging a vertically integrated CDMO from API development to finished dosage form manufacturing ⚪ EU-based manufacture of Antiseptic APIs
Merck Life Science, a division of Merck KGaA, partnes with researchers and manufacturers to enable scientific breakthroughs. We provide innovative bioprocess, lab, and analytical solutions, enabling efficient workflows, reliable quality, and accelerated timelines. Our portfolio spans cell culture, chromatography, lab essentials, and digital tools, backed by global support.
Merck Life Science partners with other companies to accelerate their success. We pursue co-creation, reliability, and measurable value across the lifecycle. We align objectives and quality, ensure supply continuity, and provide integrated materials, instruments, services, and data. We enable compliant, auditable processes and AI-enabled insights to drive growth, and resilience.
At Microomics Systems, we specialize in -omics technologies focused on microbiome analysis, including metagenomics, transcriptomics, and prokaryotic genomics. Our team of experts brings extensive experience in molecular biology, bioinformatics, and biostatistics, allowing us to deliver comprehensive and tailored solutions for every project.
Microomics provides a full-service analysis, managing every stage of the process with close attention to detail from start to finish. We operate not only as a sequencing and bioinformatics analysis company, but also as a CRO, with strong expertise in result validation through proprietary controls and pipelines.